Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience

References

• National Health Accounts Technical Secretariat. National health accounts estimates for India 2016-17 [internet]. New Delhi: National Health Systems Resource Centre; 2020. [cited 2021 Feb 8]. Available from: http://nhsrcindia.org/sites/default/files/FINAL%20National%20Health%20Accounts%202016-17%20Nov%202019-for%20Web.pdf.
   Google Scholar
• Government of India. 12th 5-Year Plan (2012–2017), Social Sectors, Volume III. 2017. [cited 2021 Feb 8]. Available from: http://planningcommission.gov.in/plans/planrel/12thplan/welcome.html.
   Google Scholar
• Ministry of Health and Family Welfare, Government of India. National health policy 2017 [internet]. New Delhi: ministry of health and family welfare, government of India; 2017. [cited 2021 Feb 8]. Available from: https://www.nhp.gov.in/nhpfiles/national_health_policy_2017.pdf.
   Google Scholar
• Teerawattananon Y, Rattanavipapong W, Lw L, et al. Landscape analysis of health technology assessment (HTA): Systems and practices in Asia. Int J Technol Assess Health Care. 2019;35(6):416–421. DOI:https://doi.org/10.1017/S0266462319000667.
   PubMed Web of Science ®Google Scholar
• Prinja S, Le D, Vk G, et al. Health technology assessment for policy making in India: current scenario and way forward. Pharmacoecon Open. 2018 Mar 2;(1):1–3. DOI:https://doi.org/10.1007/s41669-017-0037-0.
   Google Scholar
• MacQuilkan K, Baker P, Downey L, et al. Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa. Glob Health Action. 2018;11(1):1527556.
   PubMed Web of Science ®Google Scholar
• Downey LE, Mehndiratta A, Grover A, et al. Institutionalising health technology assessment: establishing the medical technology assessment board in India. BMJ Glob Health. 2017 Jun 26;2(2):e000259. DOI:https://doi.org/10.1136/bmjgh-2016-000259.
   PubMed Web of Science ®Google Scholar
• Downey LE, Dabak S, Eames J, et al. Building capacity for evidence-informed priority setting in the Indian health system: an international collaborative experience. Health Policy OPEN. 2020;1(2020):100004. DOI:https://doi.org/10.1016/j.hpopen.2020.100004
   Google Scholar
• Hailey D. The history of health technology assessment in Australia. Int J Technol Assess Health Care. 2009 Jul 25;1(S1):61–67. doi:https://doi.org/10.1017/S0266462309090436. Suppl.
   Google Scholar
• Js H, Ej M. Health technology assessment in Canada and the United States: the case of biologics. Biotechnol Healthc. 2007 Apr;4(2):47–51.
   PubMedGoogle Scholar
• Department of Community Medicine & School of Public Health [Internet]. Online certificate course in basic health economics. Healtheconomics.pgisph.in. 2020 [cited 26 December 2020]. Available from: https://www.healtheconomics.pgisph.in/school-of-public-health-basic-course.html.
   Google Scholar
• A Compendium of Health Technology Assessment in India 2017-18. HTAIn secretariat, department of health research, ministry of health & family welfare, government of India. 2019. [ Cited 2021 Feb 8]. Available from: https://htain.icmr.org.in/images/pdf/Compendium_v8.pdf
   Google Scholar
• Dd K, Cl W, Ef P, et al. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;;17(6):615–623. DOI:https://doi.org/10.1080/14737167.2017.1331432.
   PubMed Web of Science ®Google Scholar
• Jb K, Ru S, Ap B, et al. Cost-effectiveness of sacubitril valsartan combination therapy compared with enalapril for the treatment of heart failure with reduced ejection fraction. JACC Heart Fail. 2016;4(5):392–402. DOI:https://doi.org/10.1016/j.jchf.2016.02.007.
   PubMed Web of Science ®Google Scholar
• Gupta M, Prinja S, Kumar R, et al. Cost-effectiveness of Haemophilus influenza type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India. Health Policy Plan. 2013 Jan;28(1):51–61. Epub 2012 Mar 8.PMID: 22407018. . DOI:https://doi.org/10.1093/heapol/czs025.
   PubMed Web of Science ®Google Scholar
• Prinja S, Bahuguna P, Mohan P, et al. Cost effectiveness of implementing integrated management of neonatal and childhood illnesses program in district faridabad, India. PLoS One. 2016 Jan 4;;11(1):e0145043. DOI:https://doi.org/10.1371/journal.pone.0145043.
   PubMed Web of Science ®Google Scholar
• Prinja S, Bahuguna P, Gupta A, et al. Cost effectiveness of Health intervention by community health workers for reducing maternal and newborn mortality in rural Uttar Pradesh, India. Cost Eff Resour Alloc. 2018 Jun 25;16(1):25. DOI:https://doi.org/10.1186/s12962-018-0110-2.
   PubMedGoogle Scholar
• As C, Prinja S, Srinivasan R, et al. Cost effectiveness of strategies for cervical cancer prevention in India. PLoS One. 2020 Sep 1;;15(9):e0238291. DOI:https://doi.org/10.1371/journal.pone.0238291.
   PubMed Web of Science ®Google Scholar
• Sharma D, Ak A, Le D, et al. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoecon Open. 2021 Jan 10. DOI:https://doi.org/10.1007/s41669-020-00250-7.
   Google Scholar
• Gold MR, Siegel JE, Russell LB, et al., eds. Cost-Effectiveness in health and medicine. Oxford and New York:: Oxford University Press; 1996.
   Google Scholar
• Wilkinson T, Mj S, Claxton K, et al. The international decision support initiative reference case for economic evaluation: an aid to thought. value health. 2016 Dec;19(8):921–928. DOI:https://doi.org/10.1016/j.jval.2016.04.015.
   PubMed Web of Science ®Google Scholar
• Prinja S, As C, Angell B, et al. A systematic review of the state of economic evaluation for health care in India. Appl Health Econ Health Policy. 2015 Dec; 13(6):595–613. DOI:https://doi.org/10.1007/s40258-015-0201-6.
   PubMed Web of Science ®Google Scholar
• Gupta N, Rk V, Prinja S, et al. Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India. J Clin Exp Hepatol. 2019 Jul-Aug;;9(4):468–475.
   PubMed Web of Science ®Google Scholar
• Gupta N, Verma R, Rk D, et al. Cost effectiveness analysis and decision modelling: A tutorial for clinicians. J Clin Exp Hepatol. 2020;10(2):177–184.
   PubMed Web of Science ®Google Scholar
• Gupta N, Rk V, Gupta S, et al. Cost effectiveness of trastuzumab for management of breast cancer in India. JCO Global Oncology. 2020 Feb 6:;(6):205–216. DOI:https://doi.org/10.1200/JGO.19.00293
   Google Scholar
• National Sample Survey Office. Health in India- NSS 71st Round [Internet]. New Delhi: National Sample Survey Office, Ministry of Statistics and Programme Implementation; 2014. [Accessed 26 December 2020] Available from: http://mospi.nic.in/sites/default/files/publication_reports/nss_rep574.pdf
   Google Scholar
• Prinja S, Sharma Y, Dixit J, et al. cost of treatment of valvular heart disease at a tertiary hospital in north India: policy Implications. Pharmacoecon Open. 2019 Sep;3(3):391–402. DOI:https://doi.org/10.1007/s41669-019-0123-6.
   PubMed Web of Science ®Google Scholar
• Prinja S, Gupta A, Verma R, et al. Cost of delivering health care services in public sector primary and community health centres in North India. PLoS One. 2016;11(8):e0160986.
   PubMed Web of Science ®Google Scholar
• Prinja S, Gupta A, Bahuguna P, et al. Cost analysis of implementing mHealth intervention for maternal, newborn & child health care through community health workers: assessment of ReMIND program in Uttar Pradesh, India. BMC Pregnancy Childbirth. 2018 Oct 3;18(1):390.
   PubMedGoogle Scholar
• Prinja S, As C, Rajsekhar K, et al. Addressing the cost data gap for universal health care coverage in India: a national health system cost database for India. Value Health Reg Issues. 2020;21:226–229.
   PubMedGoogle Scholar
• Prinja S, Mp S, Guinness L, et al. Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol. BMJ Open. 2020 Jul 20;;10(7):e035170. DOI:https://doi.org/10.1136/bmjopen-2019-035170.
   PubMed Web of Science ®Google Scholar
• Prinja S, Brar S, Mp S, et al. CHSI Study Collaborating Investigators, Bahuguna P, Guinness L. Process evaluation of health system costing - Experience from CHSI study in India. PLoS One. 2020 May 13;;15(5):e0232873. DOI:https://doi.org/10.1371/journal.pone.0232873.
   PubMed Web of Science ®Google Scholar
• Health Benefit Package 2.0 [Internet]. National health authority. Pmjay.gov.in. 2020. [cited 2021 Feb 8]. Available from: https://pmjay.gov.in/sites/default/files/2020-09/HBP-2-0-For-Website.pdf.
   Google Scholar
• Prinja S, Mazumder S, Taneja S, et al. Cost of delivering child health care through community level health workers: how much extra does IMNCI program cost?. J Trop Pediatr. 2013;59(6):489–495.
   PubMed Web of Science ®Google Scholar
• Kumar R, Mehendale SM, Panda S, et al. Impact of targeted interventions on heterosexual transmission of HIV in India. India.BMC Public Health. 2011;11(1):549. DOI:https://doi.org/10.1186/1471-2458-11-549
   Google Scholar
• Prinja S, Kaur G, Malhotra P, et al. Cost-Effectiveness of autologous stem cell treatment as compared to conventional chemotherapy for treatment of multiple myeloma in India. Indian J Hematol Blood Transfus. 2017 Mar;33(1):31–40.
   PubMed Web of Science ®Google Scholar
• John MJ, Jyani G, Jindal A, et al. cost effectiveness of hematopoietic stem cell transplantation compared with transfusion chelation for treatment of thalassemia major. Biol Blood Marrow Transplant. 2018 Oct;24(10):2119–2126. DOI:https://doi.org/10.1016/j.bbmt.2018.04.005.
   PubMed Web of Science ®Google Scholar
• Chugh Y, Dhiman RK, Premkumar M, et al. Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India. PLoS One. 2019;14(8):e0221769.
   PubMed Web of Science ®Google Scholar
• Prinja S, Nimesh R, Gupta A, et al. Impact assessment and cost-effectiveness of m-health application used by community health workers for maternal, newborn and child health care services in rural Uttar Pradesh, India: a study protocol. Glob Health Action. 2016;9(1):31473.
   PubMed Web of Science ®Google Scholar
• Prinja S, Sundararaman T, Muraleedharan VR. Cost-effectiveness Threshold and health opportunity cost. Econ Political Wkly. 2020 Jan 11;55(2):19.
   Google Scholar
• Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data BMJ. Global Health. 2018 Nov;5:3:e000964.
   Google Scholar
• Chauhan AS, Prinja S, Ghoshal S, et al. Cost effectiveness of treating head and neck cancer using intensity modulated radiation therapy: implications for cancer control program in India. Int J Technol Assess Health Care. 2020;36(5):492-9. DOI: https://doi.org/10.1017/S0266462320000677.
   Google Scholar
• As C, Prinja S, Ghoshal S, et al. Cost of treatment for head and neck cancer in India. PLoS ONE. 2018;13(1):e0191132.
   PubMed Web of Science ®Google Scholar
• Lee N, Puri DR, Blanco AI, et al. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck. 2007;29(4):387–400.
   PubMed Web of Science ®Google Scholar
• Gaziev G, Wadhwa K, Barrett T, et al. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int. 2016 Jan;117(1):80–86. DOI:https://doi.org/10.1111/bju.12892.
   PubMed Web of Science ®Google Scholar